ABBV vs HOMB · P/E 81, rev $16.99B vs P/E 11, rev $647.9M
AbbVie Inc (ABBV) versus Home BancShares Inc (HOMB) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Home BancShares Inc (HOMB) is a banks - regional company listed on NYSE.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported HOMB revenue for 2026-06-30 was $647.9M. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
Not investment advice. Open the ABBV and HOMB stock pages for the full models.
Not investment advice.